Savage Brian, Interim Chief Legal Officer at Teva Pharmaceutical Industries Ltd. ($TEVA), sold shares on the open market four times over the last year, totaling about $164,000. His most recent sale occurred on March 5, 2026. These transactions rank him 8,830th among 11,678 insiders in our database by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Savage Brian made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | S | Ordinary Shares | 1127 | $31.67 | 10,914.0000 | 1,163,000,000 | 9.36% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Restricted Share Units | 3580 | $0.00 | 10,740.0000 | 1,163,000,000 | 25.00% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Ordinary Shares | 3580 | $0.00 | 12,041.0000 | 1,163,000,000 | 42.31% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Ordinary Shares | 3466 | $0.00 | 9,647.0000 | 1,163,000,000 | 56.08% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Restricted Share Units | 4744 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Restricted Share Units | 3766 | $0.00 | 7,534.0000 | 1,163,000,000 | 33.33% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | A | Restricted Share Units | 11280 | $0.00 | 11,280.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | S | Ordinary Shares | 1186 | $32.46 | 8,461.0000 | 1,163,000,000 | 12.29% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Ordinary Shares | 4744 | $0.00 | 7,670.0000 | 1,163,000,000 | 162.13% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | S | Ordinary Shares | 1489 | $32.46 | 6,181.0000 | 1,163,000,000 | 19.41% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Ordinary Shares | 3461 | $0.00 | 4,200.0000 | 1,163,000,000 | 468.34% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | M | Restricted Share Units | 3461 | $0.00 | 3,461.0000 | 1,163,000,000 | 50.00% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Savage Brian | Interim Chief Legal Officer | S | Ordinary Shares | 1274 | $32.36 | 2,926.0000 | 1,163,000,000 | 30.33% | 0.00% |